Delivery Order SPE2DB22D1106-SPE2DB26FDHC6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,316.42 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets (100 count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $1,377.89 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count units), with a completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,080.55 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets (100-count packages) valued at $1,859.55 with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.12 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 on July 28, 2025, with completion expected by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 5 mg tablets (100 count) valued at $1,107.73 on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,441.00 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. Performance will be completed by September 11, 2025, at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 units. This non-competitive delivery order, valued at $1,151.19 with a firm fixed price structure, was executed on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets (100 count) on September 4, 2025, with a ceiling value of $1,034.62 and completion date of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for dextroamphetamine-amphetamine 20 mg tablets (100-count supply) valued at $3,150.09 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB26FDHC6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,826.85 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets (100-count bottles) on October 15, 2025, with completion scheduled for October 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, serves as a critical supplier for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order for controlled-substance pharmaceuticals reflects the company's ongoing role in supporting federal medical supply chains and represents a routine transaction within its larger DLA relationship for pharmaceutical distribution services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/15/25 |